Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Intranasal saline is a sterile solution of sodium chloride in water, utilized as a placebo control in clinical research conducted by Virginia Polytechnic Institute and State University. In the context of studies investigating the neural correlates of memory and potential treatments for Alzheimer's disease, it is administered via the Precision Olfactory Delivery (POD) device. This delivery system targets the olfactory region to facilitate direct nose-to-brain transport, mirroring the administration of active agents like intranasal insulin. As an inert substance, saline allows for the assessment of the delivery device's effects and provides a comparative baseline to isolate the specific cognitive and neurological impacts of the experimental drug being tested.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on intranasal saline.